Peptide Goals Atlas

About the Atlas

Peptide Goals Atlas catalogs research-peptide vendors organized by what researchers are studying. Whether your work focuses on tissue recovery (TB-500, BPC-157), metabolic biology (Tirzepatide, Semaglutide), or growth-hormone secretagogue signaling (CJC-1295, Ipamorelin), we map the catalog landscape and rank vendors on documentation depth, format diversity, purity verification, shipping logistics, and pricing transparency. Independent — no affiliate priority, no sponsored placements.

Why an atlas, not a leaderboard

Most vendor "best of" lists publish one ranking and apply it across every compound. That model breaks immediately. A vendor that excels at GLP-1 supply chain — pen format, cold-chain shipping, kit curation — may be unremarkable for tissue-repair peptides where lyophilized vial volume and stack availability matter more. The same purity claim covers very different research needs.

So we built this site as an atlas. Each research goal — recovery, metabolic, growth-hormone axis, longevity, neuro, skin — gets its own ranking, with weights that reflect what would actually serve a protocol in that area. A vendor can rank #1 for one goal and #5 for another. That's not inconsistency; it's how a catalog actually maps to a research program.

What we evaluate

Independence

No vendor pays for placement on this site. We accept no affiliate commissions for top-ranked listings. We don't publish sponsored guides. If a vendor's catalog improves between updates, the next review reflects that — and if it deteriorates, the same applies. Rankings are revisited every six months.

Who writes the atlas

Dr. Marcus Whitfield, PhD

Peptide biochemistry researcher specializing in synthetic peptide characterization, cytoskeletal biology, and vendor quality evaluation. Author of the technical articles on the Atlas.

Devon Reyes

Independent vendor analyst specializing in research-grade peptide supply chains, catalog documentation standards, and GLP-1 compound sourcing. Author of the supply-chain articles on the Atlas.

Together they cover approximately 20 vendors and 50 compounds across the Atlas — a continuously updated, independent record of the research peptide market.